Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Apparent Diffusion Coefficient
27%
Baby Born
50%
Brain Development
23%
Brain Microstructure
27%
Brain MRI
18%
Brain Size
41%
Brain Structure
27%
Brain Vessels
13%
Chronic Lung Disease
13%
Corpus Callosum
27%
Cranial Ultrasound
18%
Derangement
13%
Diffusion Coefficient Measurement
9%
Diffusion Tensor Imaging
27%
Disability
13%
Double-blind Trial
27%
Early Development
13%
Expected Date of Delivery
27%
Extreme Prematurity
13%
Extremely Premature
27%
Fetal Brain
13%
Fractional Anisotropy
18%
Free Thyroxine
9%
Gestational Age
55%
Head Circumference
18%
High Risk
13%
HPA Axis
13%
Hypothalamic-pituitary Axis
13%
Hypothyroxinemia
27%
Image Quality Metrics
9%
Internal Capsule
9%
Levothyroxine
50%
Magnetic Resonance Imaging Findings
27%
Major Risk
13%
Multi-centered
13%
Myelination
27%
Neurodevelopment
27%
Neuroimaging Techniques
13%
Non-associated
9%
Occipital Lobe
9%
Oxygen Demand
13%
Placebo
50%
Plasma Concentration
9%
Premature Infant
32%
Prematurity
13%
Preterm Infants
64%
Randomized Controlled Trial
60%
Randomized Placebo-controlled Trial
37%
Sensitive Windows
13%
Somatic Growth
18%
Subarachnoid Space
27%
Term Equivalence
9%
Thyroid Function
13%
Thyroid Hormone Concentrations
18%
Thyroid Hormone Status
9%
Thyroid Hormone Supplementation
27%
Thyroid Hormones
13%
Thyroid Supplementation
9%
Thyroid Volume
13%
Thyroxine
60%
Thyroxine Supplementation
46%
Tractography
9%
Ventilation Rate
13%
Vessel Morphology
27%
White Matter Development
9%
White Matter Integrity
13%
Neuroscience
Blood Plasma
33%
Brain Development
11%
Brain Structure
13%
Corpus Callosum
13%
Developmental Disability
6%
Diffusion Tensor Imaging
13%
Fractional Anisotropy
9%
Hypothalamic-Pituitary-Adrenal Axis
6%
Levothyroxine
39%
Magnetic Resonance Imaging
27%
Magnetic Resonance Imaging of Brain
9%
Mechanical Ventilation
6%
Myelinogenesis
13%
Placebo
53%
Randomized Controlled Trial
61%
Risk Factor
6%
Somatics
12%
Subarachnoid Space
23%
Thyroid
18%
Thyroid Hormone
37%
Thyroxine
100%